SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

SARS-CoV‑2 Delta Variant Decreases Nanobody Binding and ACE2 Blocking Effectivity by Mert Golcuk (10789806)

Non-linear effects of age on the log-odds of diabetes and hypertension (posterior means along with the 97.5% credible interval are shown). by Strong P. Marbaniang (10189860)

Chronic administration of propranolol decreases airway epithelial MUC5AC expression in rats exposed to CS. by Yujiao Zhou (573776)

Collagen V oral administration decreases inflammation and remodeling of synovial membrane in experimental arthritis - Fig 3 by Silvana Ramos Atayde (5571041)

“…The Suppl and IA/Suppl groups presented decreased Col V expression compared to the IA group in the synovial adjacent tissue (arrows) and synovial membrane (arrowhead). …”

Protein degradation via the ubiquitin proteasome activity decreases with age and castration tends to increase the activity of this system. by Arik Davidyan (10450896)

Multivariable Linear Regression Model of the Residents P-V Fit score^a. by Yaotian Fan (5917766)

Subjects:

Aspirin-Triggered Resolvin D1 does not rescue barrier function in IL-1β-treated A549 cells. by Ruan Cox Jr. (789575)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

“…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”

Tetraspanins variably affect the virulence of <i>E</i>. <i>histolytica</i>. by Han Jiang (195350)

<i>Ubr5</i>^<i>mt</i> synovium exhibits markers of increased canonical and decreased non-canonical HH signalling. by David Mellis (2833469)

Absence of neocortex is associated with a dorsal shift of piriform cortex in <i>Emx1</i>-cKO mice. by Sathish Venkataramanappa (10331993)

<i>Prss21</i>^<i>-/-</i> mice display increased vascular permeability during luteal angiogenesis and decreased endothelial VE-cadherin expression. by Raymond J. Peroutka (8946971)

<i>Emx1</i>-cKO mice lack the neocortex. by Sathish Venkataramanappa (10331993)

Methyl Gallate (MG) treatment decreases hepatocellular carcinoma (HCC) cell survival. by Chien-Yu Huang (802982)

Pan-JAK inhibitor P6 decreased ISG expression and increased susceptibility of BEAS-2B cells to H1N1 influenza virus infection. by Lai-Giea Seng (644370)

“…Increased influenza virus replication in P6 treated BEAS-2B cells corresponded to decreased expression of (D) <i>IRF-7</i> (E) IL-6 (F) <i>ISG15</i> (G) <i>STING</i> (H) <i>Mx1</i> compared with the controls. …”

Tacrolimus Decreases Albuminuria in Patients with IgA Nephropathy and Normal Blood Pressure: A Double-Blind Randomized Controlled Trial of Efficacy of Tacrolimus on IgA Nephropathy by Yong-Chul Kim (1637572)

“…</p><p>Results</p><p>The mean value of pcUACR at 12-week and 16-week visits (primary outcome) was decreased more in the Tac group compared to the control group (–52.0±26.4 vs –17.3±29.3%, p = 0.001). …”